Articles tagged with Clinical Research
The Mount Sinai Health System has expanded its psychedelic psychotherapy research center with a new facility in upper Manhattan. The Center will support rigorous clinical trials for well-known compounds like MDMA, psilocybin, and ketamine, which have shown potential in alleviating symptoms of PTSD, depression, anxiety, and other stress...
Researchers at ETH Zurich have found an antidepressant, vortioxetine, effective against glioblastomas, a particularly aggressive brain tumor with no cure. The drug's ability to cross the blood-brain barrier and trigger a signalling cascade makes it promising for treating this deadly tumour.
A study finds that cardiometabolic indicators like metabolic syndrome and diabetes impair coronary microvascular function, increasing cardiovascular risk. The presence of subclinical atherosclerosis also contributes to altered microvessel function.
A new study highlights the challenges faced by women in relationships with partners diagnosed with ADHD, finding a link between their symptoms and higher rates of depression. Engaging in health-promoting activities can reduce depressive symptoms and improve well-being for these women.
Researchers developed a personalized vaccine to treat rare blood cancer, which nearly doubled disease-free progression time. The vaccine appears safe and effective in activating the immune response against tumor cells.
A new study found that vulnerable patients treated at Commission on Cancer-accredited hospitals had a 9% lower mortality rate and were more likely to receive guideline-based care. This is attributed to CoC accreditation requirements for treatment guideline adherence, community engagement, and addressing barriers to care.
A pioneering study identified critical biomarkers that can predict disability worsening in MS. Elevated serum neurofilament light chain and serum glial fibrillary acidic protein levels correlate with progression independent of relapse activity, guiding personalized treatment approaches.
The integration of artificial intelligence in intratumoral immunotherapy can refine diagnoses, guide interventions, predict treatment responses, and adapt therapeutic strategies. This enables the enhancement of patient outcomes, including improved survival rates and quality of life.
Researchers at Tel Aviv University discovered that aneuploid cells, which have an abnormal number of chromosomes, are more susceptible to certain types of anticancer drugs. The studies found that disrupting the MAPK pathway increases the sensitivity of these cancer cells to chemotherapy.
Researchers found that low extracellular sodium concentrations decrease specific mRNA expression and nitric oxide production in microglia, potentially contributing to hyponatremia-induced neuronal dysfunctions. Microglial activation can lead to inflammation and regulate neurotransmission.
A survey of UK general practitioners reveals that 20% of doctors use generative AI tools like ChatGPT in their practice. The study highlights the potential benefits of AI in reducing administrative burdens and supporting clinical decision-making, but also raises concerns about errors, biases, and patient privacy.
A new study found that patients with 4 or 5 identified risk factors, including age 18-24 years and schizophrenia spectrum disorders, had over 100 times the incidence of Neuroleptic Malignant Syndrome. The data provide a basis for early identification and monitoring of children and youth at elevated risk.
The Cancer Cooperative Group System is being re-engineered to bring new money to correlative science research through public-private partnerships, aiming to remove barriers for researchers to access biological samples. This will facilitate the integration of innovative science into cancer clinical trials.
A recent study by FAU researchers links copper regulation to neurodegenerative disorders like Alzheimer's. The team discovered that a specific gene, swip-10, plays a crucial role in maintaining the balance of copper in cells, which can prevent mitochondrial dysfunction and oxidative stress.
A recent study found significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), leading to delayed or reduced use of disease-modifying treatments. The research highlights gender disparities that could impact long-term health outcomes for women of childbearing age, particularly due to concerns about pregnanc...
A study by Amber Salter found that people with multiple sclerosis (MS) who have comorbidities experience worsened disease activity. The research highlights the importance of addressing comorbidities in MS treatment.
Researchers at UCSF have identified a molecular pathway that controls the formation of scar tissue in spinal cord injuries. By activating this pathway, they were able to reduce scarring and promote healing in mice with spinal cord injuries.
Researchers comprehensively reviewed cerebellar involvement in Parkinson's disease, highlighting the pathophysiological role of the cerebellum in motor and non-motor symptoms. Studies showed abnormal α-synuclein aggregation, neurodegeneration, and altered functional connectivity between the cerebellum and other brain regions.
ASU has created an Edward R. Roybal Center to develop and adapt technology-enabled lifestyle and behavioral interventions for older adults with cognitive decline. The center aims to help individuals maintain independence while managing challenges of aging.
Researchers found pomalidomide to be safe and effective in reducing nosebleed severity, improving quality of life, and decreasing the need for blood transfusions in adults with hereditary hemorrhagic telangiectasia. The trial stopped early due to successful findings, offering a promising treatment option for this rare bleeding disorder.
A cohort study of 1.5 million patients found that at-risk groups are disproportionately affected by denied claims for preventive services, perpetuating unequal access to high-value healthcare.
A study found that every 1% decrease in BMI leads to a 4% reduction in cardiovascular risk. Blood sugar control also lowers the risk of chronic kidney disease independently of weight change.
A meta-analysis by Mass General Brigham researchers found that Black women face higher mortality rates from breast cancer across all tumor subtypes, attributed to socioeconomic inequality, delayed diagnosis, and inadequate access to timely quality treatment. This disparity is not limited to hormone-positive tumors, with differences als...
A study by Tarang Parekh found small but significant improvements in capturing social determinants of health using Internal Classification of Diseases codes. This breakthrough research aims to better understand the impact of social factors on health outcomes and target interventions more effectively.
A new NIH-funded project aims to address gene therapy's ethical and policy challenges, gathering information from experts in six domains. The study will provide recommendations for addressing these challenges, with implications for patient safety and health outcomes.
A large-scale study will enroll 1,000 patients with acute Lyme disease to identify causes of prolonged symptoms. The research team aims to shed light on why some return to good health and others develop debilitating symptoms.
A new study presented at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood can lead to improved long-term outcomes for children with MS. The research showed a substantially lower risk of progressing to higher disability levels in the early treatment group, particularly in moderate disability range.
A new AI-based system has been shown to reduce the risk of unexpected deaths in hospitalized patients by identifying those at high risk of deteriorating health. The system, CHARTWatch, uses real-time alerts and enhanced communication between nurses and physicians to support high-quality care.
A systematic review of pharmacogenomics clinical decision support systems found that e-health tools can help integrate personalized medicine into everyday clinical practice. However, current implementation is limited, particularly in non-US healthcare systems.
A groundbreaking article proposes a transdiagnostic framework that views neurodivergent conditions as points on a spectrum rather than distinct categories. This approach acknowledges the shared characteristics and complex interplay between these conditions and recognizes their frequent overlap with mental health challenges.
A new scientific statement emphasizes the role of social determinants, such as immigration status, socioeconomic position, and access to healthcare, in shaping cardiovascular health among Asian American adults. The statement identifies future research directions to advance health equity and reduce disparities in these communities.
A team of UBC Okanagan researchers has created a new mechanical heart valve that combines the strengths of both mechanical and tissue replacement technologies, offering improved performance and durability.
A drug that delivers chemotherapy directly to tumors has shown substantial and durable activity in treating brain metastases of HER2-positive breast cancer. The treatment, trastuzumab deruxtecan, has improved progression-free survival and objective response rates in patients with advanced disease.
Researchers identified changes in the UBR4 gene as a key driver of fibromuscular dysplasia, a blood vessel disorder affecting up to five percent of adults. The discovery could lead to therapeutic approaches for the condition, particularly beneficial for women who account for 90% of cases.
A retrospective cohort study of 3,389 patients with obesity found that semaglutide and liraglutide were associated with significant weight reduction at 1 year. The study suggests that persistent medication coverage, dosage, treatment indication, and patient sex are important factors in determining weight loss outcomes.
A new $4 million grant aims to test auricular point acupressure as a treatment for chronic pain in rural populations. The project, led by UTHealth Houston and USC, will use a smartphone app to guide patients through self-administered ear stimulation.
A new study published in JAMA Health Forum found that machine learning can be more effective than traditional methods for distributing scarce treatments to patients most vulnerable during a public health crisis. The model reduces expected hospitalizations by about 27 percent compared to actual and observed care.
This study found that certain social determinants of health affect monitoring for diabetic retinopathy differently for Black and white patients with diabetes. Patients living in rural communities, including Black patients with preexisting diabetic retinopathy, are not receiving eye care in accordance with clinical practice guidelines.
Researchers are decoding genetic mutations in high-risk genes for neurodevelopmental and psychiatric disorders, including schizophrenia and depression. A new collaborative project aims to characterize the genetic origins of these disorders using human stem cells.
Researchers have introduced DSFN to improve the speed and accuracy of diagnoses of retinal disorders. This AI-powered medical imaging technique combines retina images with vascular distribution information to accurately locate the fovea in complex clinical scenarios, enabling doctors to detect early signs of ocular diseases.
CAR-T cell therapy, a regenerative immunotherapy, has shown promise in treating blood cancers but struggles with T-cell exhaustion. Researchers have discovered that overproduction of the IL-4 protein causes this exhaustion and used CRISPR gene-editing technology to remove it, improving CAR-T cell therapy outcomes.
USC Keck School of Medicine has received a $12.5 million gift from Jerre Stead to support neurological surgery innovation and entrepreneurship. Dr. Aaron Cohen-Gadol, a renowned neurosurgeon, has joined the faculty, bringing his education and innovation platform, Neurosurgical Atlas.
A groundbreaking study has provided novel insights into the molecular underpinnings of gastric cancer peritoneal spread, paving the way for more effective treatments. The research also demonstrated the safety and potential efficacy of a new treatment approach in a clinical trial.
A new study published in Annals of Oncology found that long-course radiotherapy is safer and more effective than short-course radiotherapy for preserving organs in rectal cancer patients. The treatment was shown to prevent regrowth of the primary tumour, but had similar overall survival rates.
Researchers at NTU Singapore and Oxford have identified a new process called nucleophagy that helps cells remove harmful DNA-protein lesions, promoting genetic material stability and cell survival. This discovery may improve cancer treatment outcomes for patients with colorectal cancer.
A pioneering £4.8m eight-year programme will harness artificial intelligence to investigate the link between nutrition, health inequality and the development of multiple long-term conditions. The InflAIM project aims to identify new ways to slow the progression of multiple long-term health problems in people most at risk.
A UCLA-led research team has identified degeneration-associated molecular markers shared by several forms of dementia. The study also found cell type-specific changes that underlie each condition, highlighting potential new therapeutic targets.
Researchers at WVU are working on a project to inhibit the myeloperoxidase enzyme, which feeds pancreatic cancer growth. By targeting this enzyme, they hope to boost the body's immune system to fight cancer, showing promise in mouse models and potential for future clinical trials.
This cross-sectional study examines the relationship between neighborhood opportunity and preterm birth rates, finding disproportionate exposure by race and ethnicity. The study suggests that addressing neighborhood opportunity may be a modifiable factor contributing to racial and ethnic inequities in preterm birth.
Researchers found that bringing specialists to rural patients through mobile physicians provides faster treatment and better outcomes for stroke cases treated with mechanical thrombectomy. The study's findings suggest that transferring physicians can significantly prolong patient transfer times due to complexity and coordination issues.
Researchers have proposed a novel treatment strategy for post-acute infectious syndromes (PAIS), including Long COVID. The multimodal approach combines pharmacological interventions like metformin and low-dose naltrexone with physical therapies like extracorporeal apheresis.
A study by University of East Anglia found that over a third of quitters who received free vapes in hospital emergency departments went on to experiment with different devices. Satisfaction with vaping and personal motivation were key factors for success with quitting smoking.
Researchers have successfully visualized and tracked specific cells in deep brain tissue, including along the corpus callosum's nerve fibre highway. This advancement could potentially lead to better diagnostic tools for glioblastoma, a deadly brain cancer.
Researchers propose a new approach to understanding cancer evolution, acknowledging the importance of environmental influences and epigenetic changes. By refining the clonal evolution model, they aim to develop more effective cancer therapies that consider the full complexity of cancer cell evolution.
The world's first combined whole eye and face transplant has demonstrated allograft survival, including rejection-free graft survival. The transplanted eye has maintained normal pressure, good blood flow, and some remaining structure and functions in the retina. Researchers are now focused on understanding how to restore sight.
Researchers at UCSF identified signals in the metabolic system of infants who died from Sudden Infant Death Syndrome (SIDS), finding associations between lower C-3 levels and elevated C-14OH. Elevated biomarkers also led to reduced risk of SIDS, but further research is needed to validate these findings.
A case-control study found an association between abnormal birth metabolic analytes and sudden infant death syndrome, suggesting potential early risk identification. The study's findings could inform future research and clinical efforts focused on monitoring and preventing SIDS.
Researchers at UCSF develop a method to target GTPases, enzymes involved in Parkinson's and many other diseases, by using drugs targeting the K-Ras oncogene. This approach reveals new drug binding sites that could not be predicted by computational tools.
Scientists from Spirovant Sciences describe a novel adeno-associated virus (AAV) gene therapy called SP-101 that has been optimized for efficient human airway cell transduction. After single dose inhaled delivery, the vector showed consistent expression of a functional and regulated shortened human CFTR minigene.
The FDA Letter of Support recognizes the potential of αSyn-SAA to accelerate clinical trial design in Parkinson's and related disorders. This biomarker can objectively detect early biology related to these diseases, enabling research toward tailored therapies and potentially delaying or preventing disease onset.